← Back to Search

Thrombectomy Device

Patients with acute pulmonary embolism for Pulmonary Embolism

N/A
Recruiting
Led By John Moriarty, MD
Research Sponsored by Penumbra Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 365 days
Awards & highlights

Summary

The objective of this study is to evaluate real world long-term functional outcomes, safety and performance of the Indigo Aspiration System for the treatment of pulmonary embolism (PE).

Eligible Conditions
  • Pulmonary Embolism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~365 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 365 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance: Change in RV/LV Ratio
Safety: Composite of major adverse events
Secondary outcome measures
Any-cause mortality
Functional outcome assessed NYHA
Functional outcome assessed via 6MWT
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with acute pulmonary embolismExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Indigo Aspiration System
2019
N/A
~640

Find a Location

Who is running the clinical trial?

Penumbra Inc.Lead Sponsor
36 Previous Clinical Trials
9,010 Total Patients Enrolled
2 Trials studying Pulmonary Embolism
219 Patients Enrolled for Pulmonary Embolism
John Moriarty, MDPrincipal InvestigatorUniversity of California, Los Angeles
1 Previous Clinical Trials
234 Total Patients Enrolled
1 Trials studying Pulmonary Embolism
234 Patients Enrolled for Pulmonary Embolism
~144 spots leftby Sep 2025